International Journal of Radiation Oncology*Biology*Physics
Clinical InvestigationStereotactic Irradiation of the Postoperative Resection Cavity for Brain Metastasis: A Frameless Linear Accelerator-Based Case Series and Review of the Technique
Introduction
Whole-brain radiation therapy (WBRT) is considered the evidence-based standard of care after surgical resection of a single brain metastasis. This is based on a randomized trial by Patchell et al. that demonstrated that the addition of WBRT reduces the risk of both local and distant relapse within the brain (1). Importantly, this study also demonstrated that the addition of WBRT significantly reduced the risk of neurologic death. However, the addition of WBRT did not appear to offer an overall survival advantage, although the study was not powered to address this question. Despite the proven benefits of WBRT, patients are increasingly rejecting it because to a concern regarding potential detrimental effects of WBRT on neurocognitive function. For this reason, an alternative treatment strategy employing focal radiotherapy techniques, such as stereotactic radiosurgery, hypofractionated stereotactic radiotherapy, or fractionated conventional radiotherapy, is attractive. Stereotactic radiosurgery (SRS) alone to the resection cavity is being used in many centers 2, 3, 4, 5, 6, 7, 8, 9. This approach may be a viable alternative to WBRT, offering excellent local control without compromising survival in this population.
To date, seven previous single-institution retrospective series of SRS to the postoperative resection cavity have been published (Table 1) 2, 3, 4, 5, 6, 7, 8, 9. Here we report our initial experience with frameless linear accelerator-based SRS to the postoperative resection cavity and review the technical issues pertaining to this technique. This is the first report of frameless linac-based delivery of this technique using a non-CyberKnife® (Accuray, Sunnyvale, CA) delivery platform.
Section snippets
Patients
This retrospective study was approved by the Dana-Farber/Harvard Cancer Center Institutional Review Board. We began the delivery of SRS to resection cavities after the introduction of a frameless system in 2009. All cases of SRS performed at Brigham and Women’s Hospital between January 1, 2009, and June 1, 2010, were reviewed to identify patients who received SRS to a postoperative cavity after resection of a brain metastasis. WBRT is typically offered as the standard of care in these cases.
Patient characteristics
During the study period, 167 stereotactic procedures were delivered to 102 patients. Eighteen consecutive cases of stereotactic irradiation of the resection cavity of brain metastases were identified in 17 patients. Patient characteristics are listed in Table 2. Gross total resection was achieved in 17/18 cases. The median age was 61.8 years (range, 38–81). All patients were capable of self-care, with Karnofsky performance scores of 70% or higher. The majority (76%) were RPA Class 2 patients.
Discussion
Surgical resection of a single brain metastasis has been shown to be associated with an overall survival advantage in randomized studies in patients with favorable performance status 11, 12. Surgical resection is also warranted in certain cases for the alleviation of mass effect or to provide histologic confirmation. Because of a reduction in both local and distant recurrences, WBRT is considered the evidence-based standard of care after surgical resection (1). However, WBRT can have an impact
Conclusion
Image-guided frameless stereotactic irradiation of the postoperative cavity after surgical resection of a brain metastasis appears to offer local control rates similar to those seen with whole-brain radiotherapy. This technique may defer the use of WBRT in select patients. A multicenter prospective study should be a priority to further define the optimal use of SRS in this setting.
Acknowledgments
The authors would like to thank Dr David Sher MD MPH, Edward Mannarino, Nancy Pinnell, and Barbara Silver of the Department of Radiation Oncology, Dana-Farber/Brigham and Women’s Cancer Center for their help in the preparation of this manuscript.
References (21)
- et al.
Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases
Int J Radiat Oncol Biol Phys
(2009) - et al.
Boost radiosurgery for treatment of brain metastases after surgical resections
Surg Neurol
(2008) - et al.
Stereotactic radiosurgery of the postoperative resection cavity for brain metastases
Int J Radiat Oncol Biol Phys
(2008) - et al.
A clinical comparison of patient setup and intra-fraction motion using frame-based radiosurgery versus a frameless image-guided radiosurgery system for intracranial lesions
Radiother Oncol
(2010) - et al.
Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases
J Pain Symptom Manage
(2005) - et al.
Radiosurgery with or without A 2-mm margin for 93 single brain metastases
Int J Radiat Oncol Biol Phys
(2008) - et al.
Radiosurgery for brain metastasis: impact of CTV on local control
Radiother Oncol
(2003) - et al.
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05
Int J Radiat Oncol Biol Phys
(2000) - et al.
Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial
JAMA
(1998) - et al.
Adjuvant Gamma Knife radiosurgery following surgical resection of brain metastases: A 9-year retrospective cohort study
J Neurooncol
(2010)
Cited by (0)
A travel grant was awarded by the European Association of Neurooncology.
Conflicts of interest: none.